Pathways to aggression in schizophrenia affect results of treatment

Schizophrenia Bulletin

Volumn 37, Issue 5, 2011, Pages 921-929

  Volavka, Jan ^a   Citrome, Leslie ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adherence; antipsychotics; antisocial personality disorder; psychopathy; substance use; violence

Indexed keywords

ALCOHOL; CATECHOL METHYLTRANSFERASE; CLOZAPINE; COCAINE; ILLICIT DRUG; METHIONINE; NEUROLEPTIC AGENT; OLANZAPINE; VALINE;

ACUTE STRESS; AGGRESSION; AMINO ACID SUBSTITUTION; ANTISOCIAL BEHAVIOR; CARDIAC PATIENT; CHILD ABUSE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; CONDUCT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HALLUCINATION; HUMAN; ILLNESS TRAJECTORY; IMPULSIVENESS; KNOWLEDGE; LIFE STRESS; MENTAL PATIENT; PERSONALITY DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRENATAL PERIOD; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; TREATMENT REFUSAL; VIOLENCE;

AGGRESSION; HUMANS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VIOLENCE;

EID: 80052240843     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr041     Document Type: Review

References (50)

1. Swanson JW, Holzer CE, Ganju VK, Jono RT. Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hosp Community Psychiatry. 1990;41:761-770. (Pubitemid 20244681)
2. Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009;6:e1000120.
3. Citrome L, Volavka J, Czobor P, et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility in treatment-resistant patients with schizophrenia and schizoaffective disorder. Psychiatr Serv. 2001;52:1510-1514. (Pubitemid 33029591)
4. Volavka J, Czobor P, Nolan K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004;24:225-228. (Pubitemid 38380848)
5. Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB. A typical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63:622-629. (Pubitemid 43848293)
6. Volavka J, Citrome L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int J Clin Pract. 2008;62:1237-1245. (Pubitemid 351977615)
7. Topiwala A, Fazel S. The pharmacological management of violence in schizophrenia: a structured review. Expert Rev Neurother. 2011;11:53-63.
8. Volavka J. Neurobiology of Violence. 2 ed. Washington, DC: American Psychiatric Publishing, Inc; 2002.
9. Citrome L. Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? Expert Rev Neurother. 2009;9:55-71.
10. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223. (Pubitemid 41345943)
11. Swanson JW, Swartz MS, Van Dorn RA, et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br J Psychiatry. 2008;193: 37-43. (Pubitemid 351946806)
12. Swanson JW, Van Dorn RA, Swartz MS, Smith A, Elbogen EB, Monahan J. Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behavior problems. Law Hum Behav. 2008;32:228-240. (Pubitemid 351692047)
13. Hare RD, Neumann CS. Psychopathy as a clinical and empirical construct. Annu Rev Clin Psychol. 2008;4:217-246. (Pubitemid 351668617)
14. Hart SD, Hare RD, Forth AE. Psychopathy as a risk marker for violence: development and validation of a screening version of the revised psychopathy checklist. In: Monahan J, Steadman HJ, eds. Violence and Mental Disorder. Developments in Risk Assessment. Chicago, IL: The University of Chicago Press; 1994:81-98.
15. Nolan KA, Volavka J, Mohr P, Czobor P. Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder. Psychiatr Serv. 1999;50:787-792. (Pubitemid 29258954)
16. Abushua'leh K, bu-Akel A. Association of psychopathic traits and symptomatology with violence in patients with schizophrenia. Psychiatr Res. 2006;143:205-211.
17. Hodgins S, Tiihonen J, Ross D. The consequences of conduct disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services. Schizophr Res. 2005;78:323-335. (Pubitemid 41254033)
18. Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry. 2006;67:1114-1123. (Pubitemid 44230884)
19. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry. 1998;155:835-837. (Pubitemid 28252668)
20. Han DH, Kee BS, Min KJ, et al. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport. 2006;17:95-99.
21. Kotler M, Barak P, Cohen H, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet. 1999;88:628-633.
22. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. Analysis of a functional catechol O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res. 1997;69:71-77. (Pubitemid 27147929)
23. Tosato S, Bonetto C, Di FM, et al. Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. Neurosci Lett. 2011; doi:10.1016/j.neulet. 2011.03.018.
24. Zammit S, Jones G, Jones SJ, et al. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2004;128B:19-20. (Pubitemid 38849910)
25. Fazel S, Grann M, Carlstrom E, Lichtenstein P, Langstrom N. Risk factors for violent crime in schizophrenia: a national cohort study of 13,806 patients. J Clin Psychiatry. 2009;70:362-369.
26. Fazel S, Langstrom N, Hjern A, Grann M, Lichtenstein P. Schizophrenia, substance abuse, and violent crime. JAMA. 2009;301:2016-2023.
27. Frisell T, Lichtenstein P, Langstrom N. Violent crime runs in families: a total population study of 12.5 million individuals. Psychol Med. 2011;41:97-105.
28. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl. 1989;155:59-65. (Pubitemid 19270851)
29. Swanson JW, Swartz MS, Van Dorn RA, et al. A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry. 2006;63:490-499.
30. Volavka J, Czobor P, Derks EM, et al. Efficacy of antipsychotic drugs against hostility in the European First Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry. In press.
31. Link BG, Stueve A. Psychotic symptoms and the violent/illegal behavior of mental patients compared to community controls. In: Monahan J, Steadman HJ, eds. Violence and Mental Disorder. Developments in Risk Assessment. Chicago, IL: The University of Chicago Press; 1994:137-159.
32. Junginger J, McGuire L. The paradox of command hallucinations. Psychiatr Serv. 2001;52:385.
33. Nolan KA, Czobor P, Roy BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr Serv. 2003;54:1012-1016. (Pubitemid 36793456)
34. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768-774. (Pubitemid 26021724)
35. Krakowski MI, Czobor P, Nolan KA. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J Clin Psychopharmacol. 2008;28:485-493.
36. Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002;159:1018-1028. (Pubitemid 34586949)
37. Volavka J, Swanson J. Violent behavior in mental illness: the role of substance abuse. JAMA. 2010;304:563-564.
38. Brennan PA, Mednick SA, Hodgins S. Major mental disorders and criminal violence in a Danish birth cohort. Arch Gen Psychiatry. 2000;57:494-500. (Pubitemid 30257264)
39. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2009;66:152-161.
40. Van Dorn R, Volavka J, Johnson N. Mental disorder and violence: is there a relationship beyond substance use? Soc Psychiatry Psychiatr Epidemiol. 2011; DOI 10.1007/s00127-011-0356-x.
41. Yates KF, Kunz M, Khan A, Volavka J, Rabinowitz S. Psychiatric patients with histories of aggression and crime five years after discharge from a cognitive-behavioral program. J Forensic Psychiatr Psychol. 2010;21:167-188.
42. Ascher-Svanum H, Faries DE, Zhu B, et al. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998;155:226-231.
43. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998;155:226-231. (Pubitemid 28074285)
44. Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(suppl 4):1-46.
45. Alia-Klein N, O'Rourke TM, Goldstein RZ, Malaspina D. Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample. Aggress Behav. 2007;33:86-96.
46. Lindenmayer JP, Liu-Seifert H, Kulkarni PM, et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry. 2009;70:990-996.
47. Morris RW, Weickert CS, Loughland CM. Emotional face processing in schizophrenia. Curr Opin Psychiatry. 2009;22:140-146.
48. Citrome L, Epstein H, Nolan KA, et al. Public-academic partnerships: integrating state psychiatric hospital treatment and clinical research. Psychiatr Serv. 2008;59:958-960.
49. Nolan KA, Citrome L. Reducing inpatient aggression: does paying attention pay off? Psychiatr Q. 2008;79:91-95. (Pubitemid 351748182)
50. Schwarcz G, Karajgi B. Improvement in refractory psychosis with dronabinol: four case reports. J Clin Psychiatry. 2010;71:1552-1553.